Pradhan, Bijendra RAgrawal, JPOli, KK2026-07-212026-07-212000https://hdl.handle.net/20.500.14572/6990Abstract Amphoterecin B is nowadays being used frequently as a treatment for Kalazaar (visceral leishmaniasis). Hypokalaemia induced by amphoterecin B is a recognised adverse effect and a patient on amphoterecin B therapy may develop hypokalaemic quadriparesis. Such a case of quadriparesis is presented in this report. Keywords: Hypokalaemic quadriparesis, amphoterecin B, Kalaazaren-USHypokalaemic quadriparesisamphoterecin BKalaazarArticle